This excerpt taken from the SGMO 10-K filed Mar 3, 2009.
THERAPEUTIC PRODUCT DEVELOPMENT
FACE="Times New Roman" SIZE="2">ZFP Therapeutic Product Development Programs
Our lead therapeutic development programs are based on
Table 1: Summary of current clinical programs evaluating Sangamos ZFP TF activator of